1. Melnick JZ, Baum M, Thompson JR. Aminoglycoside-induced Fanconi's syndrome. Am J Kidney Dis. 1994; 23:118–122. PMID:
8285185.
Article
2. Kang HS, Kerstan D, Dai L, Ritchie G, Quamme GA. Aminoglycosides inhibit hormone-stimulated Mg2
+ uptake in mouse distal convoluted tubule cells. Can J Physiol Pharmacol. 2000; 78:595–602. PMID:
10958159.
3. Elliott C, Newman N, Madan A. Gentamicin effects on urinary electrolyte excretion in healthy subjects. Clin Pharmacol Ther. 2000; 67:16–21. PMID:
10668849.
Article
4. Sawaya BP, Briggs JP, Schnermann J. Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties. J Am Soc Nephrol. 1995; 6:154–164. PMID:
7579079.
Article
5. Barcia JP. Hyperkalemia associated with rapid infusion of conventional and lipid complex formulations of amphotericin B. Pharmacotherapy. 1998; 18:874–876. PMID:
9692667.
6. Choudhury D, Ahmed Z. Drug-induced nephrotoxicity. Med Clin North Am. 1997; 81:705–717. PMID:
9167653.
Article
7. Sellin JH, De Soignie R. Ion transport in human colon in vitro. Gastroenterology. 1987; 93:441–448. PMID:
2440757.
Article
8. Barton CH, Pahl M, Vaziri ND, Cesario T. Renal magnesium wasting associated with amphotericin B therapy. Am J Med. 1984; 77:471–474. PMID:
6475987.
Article
9. Domingo P, Ferrer S, Cruz J, Morla R, Ris J. Trimethoprim-sulfamethoxazole-induced renal tubular acidosis in a patient with AIDS. Clin Infect Dis. 1995; 20:1435–1437. PMID:
7620045.
Article
10. Schlanger LE, Kleyman TR, Ling BN. K
+-sparing diuretic actions of trimethoprim: inhibition of Na
+ channels in A6 distal nephron cells. Kidney Int. 1994; 45:1070–1076. PMID:
8007576.
11. Choi MJ, Fernandez PC, Patnaik A, Coupaye-Gerard B, D'Andrea D, Szerlip H, Kleyman TR. Brief report: trimethoprim-induced hyperkalemia in a patient with AIDS. N Engl J Med. 1993; 328:703–706. PMID:
8433730.
12. Velázquez H, Perazella MA, Wright FS, Ellison DH. Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med. 1993; 119:296–301. PMID:
8328738.
Article
13. Rose BD. Jeffers JD, Novrozov M, editors. Metabolic acidosis. Clinical physiology of acid-base and electrolyte disorders. 1994. 4th ed. New York: McGraw-Hill;p. 540–603.
14. Morris AA, Baudouin SV, Snow MH. Renal tubular acidosis and hypophosphataemia after treatment with nucleoside reverse transcriptase inhibitors. AIDS. 2001; 15:140–141. PMID:
11192863.
Article
15. Crowther MA, Callaghan W, Hodsman AB, Mackie ID. Dideoxyinosine-associated nephrotoxicity. AIDS. 1993; 7:131–132. PMID:
8442906.
Article
16. Fisher EJ, Chaloner K, Cohn DL, Grant LB, Alston B, Brosgart CL, Schmetter B, El-Sadr WM, Sampson J. Terry Beirn Community Programs for Clinical Research on AIDS: The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial. AIDS. 2001; 15:1695–1700. PMID:
11546945.
17. Vittecoq D, Dumitrescu L, Beaufils H, Deray G. Fanconi syndrome associated with cidofovir therapy. Antimicrob Agents Chemother. 1997; 41:1846. PMID:
9257778.
Article
18. Navarro JF, Quereda C, Quereda C, Gallego N, Antela A, Mora C, Ortuno J. Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapy. Am J Kidney Dis. 1996; 27:431–434. PMID:
8604715.
Article